Form D — InSitu Biologics, Inc.
0001723443-25-000003 · filed Dec 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $8,000,000
- Reported amount sold
- $3,950,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- InSitu Biologics, Inc.
- CIK
- 1723443
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3510 HOPKINS PLACE N.
OAKDALE, Minnesota 55128 - Phone
- 651-337-4799
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Halpern · Executive OfficerOakdale, Minnesota Find on LinkedIn ↗
-
Bill Taylor · Executive OfficerOakdale, Minnesota Find on LinkedIn ↗
-
Sandi Klemann · Executive OfficerOakdale, Minnesota Find on LinkedIn ↗
-
Robert Wilson · DirectorOakdale, Minnesota Find on LinkedIn ↗
-
Greg Van Guilder · DirectorOakdale, Minnesota Find on LinkedIn ↗
-
Ivan Shaw · DirectorOakdale, Minnesota Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗